Unassociated Document
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of
1934
Date of report (Date of earliest event
reported): June 5, 2009
Neuralstem, Inc.
(Exact name of registrant as specified
in Charter)
|
Delaware
|
|
000-1357459
|
|
52-2007292
|
|
(State or other jurisdiction
of
incorporation or
organization)
|
|
(Commission File
No.)
|
|
(IRS Employee Identification
No.)
|
9700
Great Seneca Highway, Rockville, Maryland 20850
(Address of Principal Executive
Offices)
(301)
366-4841
(Issuer Telephone
number)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 3.01.
|
Notice of Delisting or Failure to
Satisfy a Continued Listing Rules or Standards; Transfer of
Listing
|
On
June 5, 2009, Neuralstem, Inc. (the “Company”) received notice from the
NYSE Amex LLC, (the “Exchange”), indicating that the Company is not in
compliance with the continued listing standard in Section 1003 (a)(i) of
the Exchange Company Guide (the “Company Guide”). The Company has been afforded
the opportunity to submit a plan of compliance to the Exchange by July 6,
2009. The Plan must demonstrate the Company’s ability to regain
compliance with the Exchange’s listing standards by December 6,
2010. In order to regain compliance, the Company must either:
(i) have shareholders equity in excess of $2,000,000, or (ii) have a market
capitalization of $50 million or more for a minimum of 30 consecutive trading
days. If the Company does not regain compliance or submit a plan
prior to July 6, 2009, or if the plan is not accepted by the Exchange, the
Company will be subject to the delisting procedures as set forth in
Section 1010 and part 12 of the Company Guide.
The
Company intends to submit a plan to the Exchange. If the plan is
accepted, the Company’s common shares will remain listed during the plan period
subject to periodic review by the Exchange to determine whether the Company is
making progress consistent with the plan. If the plan is not
accepted, the Company has the ability to appeal such
determination. During such appeal process, the Company’s common
shares will remain listed.
On
June 5, 2009, the Company issued the press release attached hereto as
Exhibit 99.1 with respect to the foregoing matters.
|
Item
9.01
|
Financial
Statement and Exhibits.
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press
Release Dated June 5, 2009
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
| |
NEURALSTEM,
INC
|
|
| |
|
|
|
|
|
By:
|
/s/ I.
Richard Garr |
|
| |
|
I.
Richard Garr |
|
| |
|
Chief Executive
Officer
|
|
| |
|
|
|